Literature DB >> 10691205

Evaluation of an automated system for identification of Enterobacteriaceae and nonfermenting bacilli.

M F Jossart1, R J Courcol.   

Abstract

The performance of the Vitek 2 (bioMérieux, France), a new fully automated system allowing rapid identification of microorganisms and susceptibility testing, and the Vitek 2 ID-GNB card (bioMérieux) was evaluated using 502 clinical isolates and stock collection strains of gram-negative rods belonging to 70 taxa. The number of isolates correctly identified to species and genus levels was 430 (85.7%) and 485 (96.6%), respectively. Clinical isolates of both Enterobacteriaceae and non-Enterobacteriaceae were better identified at the species level (95.3% and 74%, respectively) than stock collection strains (86.4% and 52.2%, respectively). The Vitek 2 ID-GNB card provides after 3 h a highly acceptable level of accuracy for identification of Enterobacteriaceae and non-Enterobacteriaceae, including most atypical strains encountered in clinical situations.

Mesh:

Substances:

Year:  1999        PMID: 10691205     DOI: 10.1007/s100960050429

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  18 in total

1.  Evaluation of VITEK 2 rapid identification and susceptibility testing system against gram-negative clinical isolates.

Authors:  T K Ling; P C Tam; Z K Liu; A F Cheng
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

2.  Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital.

Authors:  C C Sanders; M Peyret; E S Moland; S J Cavalieri; C Shubert; K S Thomson; J M Boeufgras; W E Sanders
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

3.  Accuracy of six commercially available systems for identification of members of the family vibrionaceae.

Authors:  Caroline M O'Hara; Evangeline G Sowers; Cheryl A Bopp; Sarah B Duda; Nancy A Strockbine
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

4.  Evaluation of the Vitek 2 system for rapid identification of clinical isolates of gram-negative bacilli and members of the family Streptococcaceae.

Authors:  P J Gavin; J R Warren; A A Obias; S M Collins; L R Peterson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-12-10       Impact factor: 3.267

5.  Evaluation of the VITEK 2 system for rapid direct identification and susceptibility testing of gram-negative bacilli from positive blood cultures.

Authors:  Thomas K W Ling; Z K Liu; Augustine F B Cheng
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

6.  Evaluation of the new VITEK 2 card for identification of clinically relevant gram-negative rods.

Authors:  Guido Funke; Pascale Funke-Kissling
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

7.  Evaluation of the automated phoenix system for potential routine use in the clinical microbiology laboratory.

Authors:  J-L Donay; D Mathieu; P Fernandes; C Prégermain; P Bruel; A Wargnier; I Casin; F X Weill; P H Lagrange; J L Herrmann
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

Review 8.  Manual and automated instrumentation for identification of Enterobacteriaceae and other aerobic gram-negative bacilli.

Authors:  Caroline M O'hara
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

9.  Evaluation of the new Vitek 2 GN card for the identification of gram-negative bacilli frequently encountered in clinical laboratories.

Authors:  F N R Renaud; E Bergeron; S Tigaud; C Fuhrmann; B Gravagna; J Freney
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-10       Impact factor: 3.267

10.  Evaluation of the Vitek 2 ID-GNB assay for identification of members of the family Enterobacteriaceae and other nonenteric gram-negative bacilli and comparison with the Vitek GNI+ card.

Authors:  Caroline M O'Hara; J Michael Miller
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.